Advanced search
Publication Cover
Substance Abuse Volume 33, 2012 - Issue 1: Pharmacotherapies for Opioid Dependence in Criminal Justice Populations
Journal homepage
1,749
Views
159
CrossRef citations to date
0
Altmetric
Original Articles

Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions

Peter D. Friedmann MD, MPH Rhode Island Unified Research Center, General Medicine Research Unit, Rhode Island Hospital, Providence, Rhode Island, USA; University of Rhode Island, Kingston, Rhode Island, USA; University of Puerto Rico, San Juan, Puerto Rico
,
Randall Hoskinson Jr. MA Rhode Island Unified Research Center, General Medicine Research Unit, Rhode Island Hospital, Providence, Rhode Island, USA; University of Rhode Island, Kingston, Rhode Island, USA; University of Puerto Rico, San Juan, Puerto Rico
,
Michael Gordon DPA Maryland Research Center, Friends Research Institute, Inc., Baltimore, Maryland, USA
,
Robert Schwartz MD Maryland Research Center, Friends Research Institute, Inc., Baltimore, Maryland, USA
,
Timothy Kinlock PhD Maryland Research Center, Friends Research Institute, Inc., Baltimore, Maryland, USA
,
Kevin Knight PhD Southwest Research Center, Institute for Behavioral Research, Texas Christian University, Fort Worth, Texas, USA
,
Patrick M. Flynn PhD Southwest Research Center, Institute for Behavioral Research, Texas Christian University, Fort Worth, Texas, USA
,
Wayne N. Welsh PhD Pennsylvania Research Center at Temple University, Philadelphia, Pennsylvania, USA; Commonwealth of Pennsylvania Department of Corrections, Camp Hill, Pennsylvania, USA
,
Lynda A. R. Stein PhD Rhode Island Unified Research Center, General Medicine Research Unit, Rhode Island Hospital, Providence, Rhode Island, USA; University of Rhode Island, Kingston, Rhode Island, USA; University of Puerto Rico, San Juan, Puerto Rico
,
Stanley Sacks PhD Rocky Mountains Research Center, National Development and Research Institute, Inc., New York, New York, USA
,
Daniel J. O’Connell PhD Mid-States Research Center, Center for Drug and Alcohol Studies, University of Delaware, Newark, Delaware, USA
,
Hannah K. Knudsen PhD Central States Research Center, Center for Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky, USA
,
Michael S. Shafer PhD Center for Applied Behavioral Research Policy, Arizona State University, Phoenix, Arizona, USA
,
Elizabeth Hall PhD Pacific Coast Research Center, Integrated Substance Abuse Programs, University of California, Los Angeles, California, USA
,
Linda K. Frisman PhD Connecticut Research Center, University of Connecticut, CT Department of Correction, Hartford, Connecticut, USA
&
for the MAT Working Group of CJ-DATS Rhode Island Unified Research Center, General Medicine Research Unit, Rhode Island Hospital, Providence, Rhode Island, USA; University of Rhode Island, Kingston, Rhode Island, USA; University of Puerto Rico, San Juan, Puerto Rico; Maryland Research Center, Friends Research Institute, Inc., Baltimore, Maryland, USA; Southwest Research Center, Institute for Behavioral Research, Texas Christian University, Fort Worth, Texas, USA; Pennsylvania Research Center at Temple University, Philadelphia, Pennsylvania, USA; Commonwealth of Pennsylvania Department of Corrections, Camp Hill, Pennsylvania, USA; Rocky Mountains Research Center, National Development and Research Institute, Inc., New York, New York, USA; Mid-States Research Center, Center for Drug and Alcohol Studies, University of Delaware, Newark, Delaware, USA; Central States Research Center, Center for Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky, USA; Center for Applied Behavioral Research Policy, Arizona State University, Phoenix, Arizona, USA; Pacific Coast Research Center, Integrated Substance Abuse Programs, University of California, Los Angeles, California, USA; Connecticut Research Center, University of Connecticut, CT Department of Correction, Hartford, Connecticut, USA
 show all
Pages 9-18 | Published online: 20 Jan 2012

Citations (159)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (27)

Thomas R. Blue, Jesse B. Fletcher, Laura B. Monico, Michael S. Gordon, Robert P. Schwartz & Shannon Gwin Mitchell. (2023) Jail and treatment staff attitudes regarding MOUDs before and after an implementation intervention. Journal of Offender Rehabilitation 62:7, pages 411-426.
Read now
Lindsay R. Smith, Fanni Faragó, Thomas Blue, James C. Witte, Michael S. Gordon & Faye S. Taxman. (2023) Viewing Then Doing?: Problem-Solving Court Coordinators’ Perceptions of Medications for Opioid Use Disorders from a Nationally Representative Survey in the United States. Substance Use & Misuse 0:0, pages 1-9.
Read now
Jordan M. Hyatt, Kathleen Powell, Nicolette K. Bell, K. Bret Bucklen & Daniel Langleben. (2023) Assessment of Attitudes Towards Medication-Assisted Drug Treatment Options among an Incarcerated Population. Corrections 8:4, pages 344-370.
Read now
John R. Gallagher, Anthony Estreet, Anne Nordberg, Courtney Zongrone, Raychel M. Minasian & Sydney Szymanowski. (2023) The interplay between women, opioid use disorder, medication-assisted treatment (MAT), and drug court: A qualitative study. Journal of Human Behavior in the Social Environment 33:5, pages 647-662.
Read now
Jon Lepley. (2023) President’s message. Journal of Addictive Diseases 41:2, pages 117-119.
Read now
Ian A. Silver & Christopher D’Amato. (2023) The within-individual lagged effects of time spent incarcerated on substance use: a nationally representative longitudinal study from the United States. Journal of Substance Use 28:1, pages 26-33.
Read now
Barbara Andraka-Christou, MH Clark, Danielle N. Atkins & Brandon del Pozo. (2022) Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder. Substance Abuse 43:1, pages 425-432.
Read now
Ekaterina Pivovarova, Hye Sung Min & Peter D. Friedmann. (2021) Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders. Substance Abuse 42:4, pages 618-624.
Read now
Harlan Matusow, Andrew Rosenblum & Chunki Fong. (2021) Online Medication Assisted Treatment Education for Court Professionals: Need, Opportunities and Challenges. Substance Use & Misuse 56:10, pages 1439-1447.
Read now
Carolyn B. Sufrin & Andrea Knittel. (2021) Health care and social justice implications of incarceration for pregnant people who use drugs. International Review of Psychiatry 33:6, pages 557-571.
Read now
John R. Gallagher, Anne Nordberg, Zephi Francis, Preeti Menon, Meredith Canada & Raychel M. Minasian. (2021) A Focus Group Analysis with a Drug Court Team: Opioid Use Disorders and the Role of Medication-Assisted Treatment (MAT) in Programming. Journal of Social Work Practice in the Addictions 21:2, pages 139-148.
Read now
Noa Krawczyk, Ramin Mojtabai, Elizabeth A. Stuart, Michael I. Fingerhood, Deborah Agus, B. Casey Lyons, Jonathan P. Weiner & Brendan Saloner. (2021) Opioid agonist treatment is highly protective against overdose death among a U.S. statewide population of justice-involved adults. The American Journal of Drug and Alcohol Abuse 47:1, pages 117-126.
Read now
Jennifer Miles, Jason Howell, Dave Sheridan, George Braucht & Amy Mericle. (2020) Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic. The American Journal of Drug and Alcohol Abuse 46:3, pages 266-272.
Read now
Emma R. Brezel, Tia Powell & Aaron D. Fox. (2020) An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated. Substance Abuse 41:2, pages 150-154.
Read now
Shannon Streisel & Ronet Bachman. (2020) An extension of collateral consequences: Impact on the recovery process. Journal of Offender Rehabilitation 59:1, pages 1-21.
Read now
Yang Yang, Julie Gray, George W. Joe, Patrick M. Flynn & Kevin Knight. (2019) Treatment Retention Satisfaction, and Therapeutic Progress for Justice-Involved Individuals Referred to Community-Based Medication-Assisted Treatment. Substance Use & Misuse 54:9, pages 1461-1474.
Read now
Michael Fendrich & Thomas P. LeBel. (2019) Implementing access to medication assisted treatment in a drug treatment court: Correlates, consequences, and obstacles. Journal of Offender Rehabilitation 58:3, pages 178-198.
Read now
Molly Doernberg$suffix/text()$suffix/text(), Noa Krawczyk$suffix/text()$suffix/text(), Deborah Agus$suffix/text()$suffix/text() & Michael Fingerhood$suffix/text()$suffix/text(). (2019) Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?. Substance Abuse 40:2, pages 148-153.
Read now
Steven Belenko. (2019) The role of drug courts in promoting desistance and recovery: a merging of therapy and accountability. Addiction Research & Theory 27:1, pages 3-15.
Read now
S. E. Streisel. (2018) Intent to Refer: Exploring Bias Toward Specific Medication-Assisted Treatments by Community Corrections Employees. Substance Use & Misuse 53:14, pages 2421-2430.
Read now
Robert P. Schwartz, Mary M. Mitchell, Kevin E. O’Grady, Sharon M. Kelly, Jan Gryczynski, Shannon Gwin Mitchell, Michael S. Gordon & Jerome H. Jaffe. (2018) Pharmacotherapy for opioid addiction in community corrections. International Review of Psychiatry 30:5, pages 117-135.
Read now
Hilary L. Surratt, Michele Staton, Carl G. Leukefeld, Carrie B. Oser & J. Matthew Webster. (2018) Patterns of buprenorphine use and risk for re-arrest among highly vulnerable opioid-involved women released from jails in rural Appalachia. Journal of Addictive Diseases 37:1-2, pages 1-4.
Read now
Erin M. Kerrison. (2017) An historical review of racial bias in prison-based substance abuse treatment design. Journal of Offender Rehabilitation 56:8, pages 567-592.
Read now
Laura B. Monico, Shannon Gwin Mitchell, Wayne Welsh, Nathan Link, Leah Hamilton, Shawna Malvini Redden, Robert P. Schwartz & Peter D. Friedmann. (2016) Developing effective interorganizational relationships between community corrections and community treatment providers. Journal of Offender Rehabilitation 55:7, pages 484-501.
Read now
Leah Hamilton & Steven Belenko. (2016) Effects of Pre-release Services on Access to Behavioral Health Treatment after Release from Prison. Justice Quarterly 33:6, pages 1080-1102.
Read now
Michael S. Gordon, Timothy W. Kinlock, Robert P. Schwartz, Kathryn A. Couvillion, Laura J. Sudec, Kevin E. O’Grady, Frank J. Vocci & Hamin Shabazz. (2015) Buprenorphine Treatment for Probationers and Parolees. Substance Abuse 36:2, pages 217-225.
Read now
Warren Harlow, Marian W. Roman, Brenda Happell & Graeme Browne. (2013) Accessibility Versus Quality of Care Plus Retention: The Formula for Service Delivery in Australian Opioid Replacement Therapy?. Issues in Mental Health Nursing 34:9, pages 706-714.
Read now

Articles from other publishers (132)

Spencer G. Lawson, Chelsea M.A. Foudray, Evan M. Lowder, Bradley Ray & Kory L. Carey. (2024) The role of co-occurring disorders in criminal recidivism and psychiatric recovery among adults with opioid use disorder and criminal-legal involvement: A statewide retrospective cohort study. Journal of Substance Use and Addiction Treatment 156, pages 209192.
Crossref
Blythe E. Rhodes, Jessica Carda-Auten, Elena A. DiRosa & David L. Rosen. (2023) Provision of health care services related to substance use disorder in southern U.S. jails. Journal of Substance Use and Addiction Treatment, pages 209234.
Crossref
Elias M. Klemperer, Elizabeth A. Evans & Richard Rawson. (2023) A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated. Preventive Medicine 176, pages 107647.
Crossref
Dharushana Muthulingam, Thomas C. Hassett, Lynn M. Madden, Daniel J. Bromberg, Liana Fraenkel & Frederick L. Altice. (2023) Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis. Journal of Substance Use and Addiction Treatment 154, pages 209138.
Crossref
Serra Sozen, David Krag & Carly Milliren. (2023) Opioid dependence among pregnant and post-partum incarcerated individuals: A review of the literature. Journal of Opioid Management 19:7, pages 123-133.
Crossref
Abinaya RamakrishnanCarrie E. Fry. (2023) Equity Implications of the Affordable Care Act Among People With Past-Year Criminal Legal Interactions. Psychiatric Services, pages 00-00.
Crossref
Grant Victor, Bradley Ray, Brandon del Pozo, Kaitlyn Jaffe, Andy King & Philip Huynh. (2023) Buprenorphine and opioid analgesics: Dispensation and discontinuity among accidental overdose fatalities in the Indianapolis metropolitan area, 2016–2021. Journal of Substance Use and Addiction Treatment 150, pages 209053.
Crossref
Lynn Kao, Chanel Lee, Trisha Parayil, Camille Kramer & Carolyn B. Sufrin. (2023) Assessing provision of MOUD and obstetric care in U.S. jails: A content analysis of policies submitted by 59 jails. Drug and Alcohol Dependence 248, pages 109877.
Crossref
Marisa D. Booty, Kathi Harp, Evan Batty, Hannah K. Knudsen, Michele Staton & Carrie B. Oser. (2023) Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians. Journal of Substance Use and Addiction Treatment 149, pages 209051.
Crossref
J.W. Andrew Ranson, Ashley N. Arnio & Jennifer E. Copp. (2023) Jurisdictional context and the (over)use of pretrial detention. Social Science Research 112, pages 102872.
Crossref
Fanni Farago, Thomas R. Blue, Lindsay Renee Smith, James C. Witte, Michael Gordon & Faye S. Taxman. (2022) Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators. Journal of Drug Issues 53:2, pages 296-320.
Crossref
Ekaterina Pivovarova, Faye S. Taxman, Alexandra K. Boland, David A. Smelson, Stephenie C. Lemon & Peter D. Friedmann. (2023) Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers. Journal of Substance Use and Addiction Treatment 147, pages 208950.
Crossref
Mindy R. Waite, Kayla Heslin, Jonathan Cook, Aengela Kim & Michelle Simpson. (2023) Predicting substance use disorder treatment follow-ups and relapse across the continuum of care at a single behavioral health center. Journal of Substance Use and Addiction Treatment 147, pages 208933.
Crossref
Carrie B Oser, Evan Batty, Marisa Booty, Kate Eddens, Hannah K Knudsen, Brea Perry, Maria Rockett & Michele Staton. (2023) Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the G eographic variation in A ddiction T reatment E xperiences (GATE) longitudinal cohort study protocol . BMJ Open 13:3, pages e066068.
Crossref
Debbie Ann Loh, Emma Plugge & Marie-Claire Van Hout. (2023) Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review. International Journal of Drug Policy 112, pages 103957.
Crossref
Shayna S. Bassett & Daniel J. Delaney. 2023. The History and Future of Correctional Psychology. The History and Future of Correctional Psychology 217 237 .
Christy K. Scott, Christine E. Grella, Michael L. Dennis, John Carnevale & Robin LaVallee. (2022) Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.. Health & Justice 10:1.
Crossref
Rosemarie A. Martin, Justin Berk, Josiah D. Rich, Augustine Kang, John Fritsche & Jennifer G. Clarke. (2022) Use of long-acting injectable buprenorphine in the correctional setting. Journal of Substance Abuse Treatment 142, pages 108851.
Crossref
Atsushi Matsumoto, Claudia Santelices, Elizabeth A. Evans, Ekaterina Pivovarova, Thomas J. Stopka, Warren J. Ferguson & Peter D. Friedmann. (2022) Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. International Journal of Drug Policy 109, pages 103823.
Crossref
Steven Belenko, Richard Dembo, Danica K. Knight, Katherine S. Elkington, Gail A. Wasserman, Angela A. Robertson, Wayne N. Welsh, James Schmeidler, George W. Joe & Tisha Wiley. (2022) Using structured implementation interventions to improve referral to substance use treatment among justice-involved youth: Findings from a multisite cluster randomized trial. Journal of Substance Abuse Treatment 140, pages 108829.
Crossref
Natalie Swartz, Tatheer Adnan, Flavia Peréa, Travis P. Baggett & Avik Chatterjee. (2022) “Sick and tired of being sick and tired”: Exploring initiation of medications for opioid use disorder among people experiencing homelessness. Journal of Substance Abuse Treatment 138, pages 108752.
Crossref
Rita Komalasari. 2022. Handbook of Research on Mathematical Modeling for Smart Healthcare Systems. Handbook of Research on Mathematical Modeling for Smart Healthcare Systems 374 382 .
Kelly E. Moore, Shania L. Siebert, Rachelle Kromash, Mandy D. Owens & Diamond C. Allen. (2022) Negative attitudes about medications for opioid use disorder among criminal legal staff. Drug and Alcohol Dependence Reports 3, pages 100056.
Crossref
Megan Kurz, Laura M. Dale, Jeong Eun Min, Natt Hongdilokkul, Leigh Greiner, Maureen Olley, Katherine E. McLeod, Amanda Slaunwhite & Bohdan Nosyk. (2021) Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada. Addiction 117:5, pages 1353-1362.
Crossref
Ekaterina Pivovarova, Elizabeth A. Evans, Thomas J. Stopka, Claudia Santelices, Warren J. Ferguson & Peter D. Friedmann. (2022) Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug and Alcohol Dependence 234, pages 109394.
Crossref
Allison J. OberSarah B. HunterColleen M. McCulloughIsabel LeamonMichael McCrearyIvan BeasAlanna MonteroDerjung M. TarnElizabeth BromleyBrian HurleyJohn SheeheJeremy MartinezKatherine E. Watkins. (2022) Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment Willingness. Psychiatric Services 73:3, pages 271-279.
Crossref
Riley D. Shearer, Nathan D. Shippee, Kathrine Diaz Vickery, Maria A. Stevens & Tyler N.A. Winkelman. (2022) A longitudinal cross-sectional analysis of substance use treatment trends for individuals experiencing homelessness, criminal justice involvement, both, or neither - United States, 2006-2018. The Lancet Regional Health - Americas 7, pages 100174.
Crossref
Andrea K. Knittel, Rita A. Swartzwelder, Samantha Zarnick, Tamy Harumy Moraes Tsujimoto, Timelie Horne, Feng-Chang Lin, James Edwards, Elton Amos, James Alexander, John Thorp & Hendree E. Jones. (2022) Medications for opioid use disorder during pregnancy: Access and continuity in a state women’s prison facility, 2016–2019. Drug and Alcohol Dependence 232, pages 109308.
Crossref
C. Clare Strange, Sarah M. Manchak, Jordan M. Hyatt, Damon M. Petrich, Alisha Desai & Cory P. Haberman. (2022) Opioid‐specific medication‐assisted therapy and its impact on criminal justice and overdose outcomes. Campbell Systematic Reviews 18:1.
Crossref
Ariel Ludwig, Laura B. Monico, Thomas Blue, Michael S. Gordon, Robert P. Schwartz & Shannon Gwin Mitchell. (2022) Development and use of a checklist for the implementation of medication for opioid use disorder in jails. Implementation Research and Practice 3, pages 263348952211012.
Crossref
Heino Stöver, Jörg Pont, Hans Wolff & Stefan Enggist. 2022. Human Rights Behind Bars. Human Rights Behind Bars 245 264 .
Christy K. Scott, Michael L. Dennis, Christine E. Grella, Allison F. Mischel & John Carnevale. (2021) The impact of the opioid crisis on U.S. state prison systems. Health & Justice 9:1.
Crossref
Michele Staton, Hannah K. Knudsen, Sharon L. Walsh, Carrie Oser, Erika Pike & Michelle Lofwall. (2021) Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUD. Health & Justice 9:1.
Crossref
Rita Komalasari, Sarah Wilson & Sally Haw. (2021) A social ecological model (SEM) to exploring barriers of and facilitators to the implementation of opioid agonist treatment (OAT) programmes in prisons. International Journal of Prisoner Health 17:4, pages 477-496.
Crossref
Jacob D. Armstrong, Amy Bauman, Krystal J. Moroney & C. Brendan Clark. 2021. Addictions - Diagnosis and Treatment. Addictions - Diagnosis and Treatment.
Noor Taweh, Esther Schlossberg, Cynthia Frank, Ank Nijhawan, Irene Kuo, Kevin Knight & Sandra A. Springer. (2021) Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions. International Journal of Drug Policy 96, pages 103283.
Crossref
Alissa Haas, Adam Viera, Molly Doernberg, Russell Barbour, Guangyu Tong, Lauretta E. Grau & Robert Heimer. (2021) Post-incarceration outcomes for individuals who continued methadone treatment while in Connecticut jails, 2014–2018. Drug and Alcohol Dependence 227, pages 108937.
Crossref
Elizabeth Needham Waddell, Sandra A. Springer, Lisa A. Marsch, David Farabee, Robert P. Schwartz, Amesika Nyaku, Rusty Reeves, Keith Goldfeld, Ryan D. McDonald, Mia Malone, Anna Cheng, Elizabeth C. Saunders, Laura Monico, Jan Gryczynski, Kathleen Bell, Kasey Harding, Sandra Violette, Thomas Groblewski, Wendy Martin, Kasey Talon, Nicole Beckwith, Andrew Suchocki, Randy Torralva, Jennifer P. Wisdom & Joshua D. Lee. (2021) Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). Journal of Substance Abuse Treatment 128, pages 108389.
Crossref
Todd Molfenter, Jessica Vechinski, Faye S. Taxman, Alex J. Breno, Cameron C. Shaw & Heather A. Perez. (2021) Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use. Journal of Substance Abuse Treatment 128, pages 108370.
Crossref
Rosemarie A. Martin, L.A.R. Stein, Damaris J. Rohsenow, Steven Belenko, Linda E. Hurley, Jennifer G. Clarke & Lauren Brinkley-Rubinstein. (2021) Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol. Journal of Substance Abuse Treatment 128, pages 108364.
Crossref
Katherine S. Elkington, Edward Nunes, Annie Schachar, Margaret E. Ryan, Alejandra Garcia, Kelly Van DeVelde, Dennis Reilly, Megan O'Grady, Arthur R. Williams, Susan Tross, Patrick Wilson, Renee Cohall, Alwyn Cohall & Milton Wainberg. (2021) Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults. Journal of Substance Abuse Treatment 128, pages 108277.
Crossref
Elizabeth A. Evans, Thomas J. Stopka, Ekaterina Pivovarova, Sean M. Murphy, Faye S. Taxman, Warren J. Ferguson, Dana Bernson, Claudia Santelices, Kathryn E. McCollister, Randall HoskinsonJrJr, Thomas Lincoln, Peter D. Friedmann, Sheriff Kevin F. Coppinger, Jason Faro, Sheriff Christopher J. Donelan, Edmond Hayes, Sheriff Nicholas Cocchi, Martha Lyman, Thomas Lincoln, Sheriff Patrick J. Cahillane, Melinda Cady, Sheriff Peter J. Koutoujian, Kashif Siddiqi, Dan Lee, Sheriff Jerome P. McDermott, Tara Flynn, Erika Sica, Sheriff Steven W. Tompkins, Rachelle Steinberg & Marjorie Bernadeau-Alexandre. (2021) Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). Journal of Substance Abuse Treatment 128, pages 108275.
Crossref
Michael S. Gordon, Shannon Gwin Mitchell, Thomas R. Blue, Frank J. Vocci, Marc J. Fishman, Sean M. Murphy, Kathy Couvillion, Kelly Maher, Danielle Ryan, Kevin Wenzel, Martha L. Danner & Daniel K. Jarvis. (2021) A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail. Journal of Substance Abuse Treatment 128, pages 108241.
Crossref
Alene Kennedy-Hendricks, Sachini Bandara, Sydney Merritt, Colleen L. Barry & Brendan Saloner. (2021) Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision. Drug and Alcohol Dependence 226, pages 108881.
Crossref
George E. Woody, Sabrina Poole, Elmer Yu, John Carroll & Kevin G. Lynch. (2021) Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison. Journal of Substance Abuse Treatment 127, pages 108355.
Crossref
William Vail, Elissa Faro, Dana Watnick, Jonathan Giftos & Aaron D. Fox. (2021) Does incarceration influence patients’ goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail. Drug and Alcohol Dependence 222, pages 108529.
Crossref
Magdalena CerdáNoa KrawczykLeah HamiltonKara E. RudolphSamuel R. FriedmanKatherine M. Keyes. (2021) A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic. Annual Review of Public Health 42:1, pages 95-114.
Crossref
Laura B. Monico, Jan Gryczynski, Joshua D. Lee, Kristi Dusek, Ryan McDonald, Mia Malone, Anjalee Sharma, Anna Cheng, Angela DeVeaugh-Geiss & Howard Chilcoat. (2021) Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration. Journal of Substance Abuse Treatment 123, pages 108267.
Crossref
Andrea K. Finlay, Alex H. S. Harris, Christine Timko, Mengfei Yu, David Smelson, Matthew Stimmel & Ingrid A. Binswanger. (2021) Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of Addiction Medicine 15:2, pages 143-149.
Crossref
C. Clare Strange, Sarah M. Manchak, Jordan M. Hyatt, Cory Haberman & Alisha Desai. (2021) PROTOCOL: Opioid‐specific medication‐assisted therapy and its impact on criminal justice and overdose outcomes. Campbell Systematic Reviews 17:1.
Crossref
Christine E. Grella, Erika Ostlie, Christy K. Scott, Michael L. Dennis, John Carnevale & Dennis P. Watson. (2021) A scoping review of factors that influence opioid overdose prevention for justice-involved populations. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Clayton A. BarnesAndrea N. PonceRachel Loewy. (2021) Recommendations to Improve Medication-Assisted Treatment Implementation in Correctional Health. Psychiatric Services 72:2, pages 233-234.
Crossref
Benjamin P. Linas, Alexandra Savinkina, R. W. M. A. Madushani, Jianing Wang, Golnaz Eftekhari Yazdi, Avik Chatterjee, Alexander Y. Walley, Jake R. Morgan, Rachel L. Epstein, Sabrina A. Assoumou, Sean M. Murphy, Bruce R. Schackman, Stavroula A. Chrysanthopoulou, Laura F. White & Joshua A. Barocas. (2021) Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Network Open 4:2, pages e2037259.
Crossref
Karen Chan Osilla, Kirsten Becker, Liisa Ecola, Brian Hurley, Jennifer K. Manuel, Allison Ober, Susan M. Paddock & Katherine E. Watkins. (2020) Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone. Addiction Science & Clinical Practice 15:1.
Crossref
Sean M. Murphy, Philip J. Jeng, Sabrina A. Poole, Ali Jalali, Frank J. Vocci, Michael S. Gordon, George E. Woody & Daniel Polsky. (2020) Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials. Addiction Science & Clinical Practice 15:1.
Crossref
Lincoln Sloas, Jennifer Lerch, Scott Walters & Faye S. Taxman. (2020) Individual-Level Predictors of the Working Relationship between Probation Officers and Probationers. The Prison Journal 100:6, pages 709-725.
Crossref
Ingrid A. Binswanger, Anh P. Nguyen, Jeffrey D. Morenoff, Stanley Xu & David J. Harding. (2020) The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study. Addiction 115:12, pages 2329-2338.
Crossref
Martin Krsak, Brian T Montague, Paul Trowbridge, Steven C Johnson & Ingrid A Binswanger. (2020) Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. The Journal of Infectious Diseases 222:Supplement_5, pages S486-S493.
Crossref
Daniel Winetsky, Aaron Fox, Ank Nijhawan & Josiah D. Rich. (2020) Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System. Infectious Disease Clinics of North America 34:3, pages 585-603.
Crossref
Andrea K. Knittel, Samantha Zarnick, John M. ThorpJr.Jr., Elton Amos & Hendree E. Jones. (2020) Medications for opioid use disorder in pregnancy in a state women’s prison facility. Drug and Alcohol Dependence 214, pages 108159.
Crossref
Andrea K. Finlay, Erica Morse, Matthew Stimmel, Emmeline Taylor, Christine Timko, Alex H. S. Harris, David Smelson, Mengfei Yu, Jessica Blue-Howells & Ingrid A. Binswanger. (2020) Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. Journal of General Internal Medicine 35:9, pages 2529-2536.
Crossref
Christine E. Grella, Erika Ostile, Christy K Scott, Michael Dennis & John Carnavale. (2020) A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System. International Journal of Drug Policy 81, pages 102768.
Crossref
Barbara Andraka-Christou, Thuy Nguyen, David W. Bradford & Kosali Simon. (2020) Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder. Journal of Substance Abuse Treatment 110, pages 49-58.
Crossref
Julie Hanna, Sheryl Kubiak, Emily Pasman, Ayorkor Gaba, Michael Andre, David Smelson & Debra A. Pinals. (2020) Evaluating the implementation of a prisoner re-entry initiative for individuals with opioid use and mental health disorders: Application of the consolidated framework for implementation research in a cross-system initiative. Journal of Substance Abuse Treatment 108, pages 104-114.
Crossref
Theddeus Iheanacho, Ayana Jordan & Charles Dike. 2020. Absolute Addiction Psychiatry Review. Absolute Addiction Psychiatry Review 289 304 .
Monica Malta, Thepikaa Varatharajan, Cayley Russell, Michelle Pang, Sarah Bonato & Benedikt Fischer. (2019) Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. PLOS Medicine 16:12, pages e1003002.
Crossref
Apostolos A. Alexandridis, Nabarun Dasgupta, Agnieszka D. McCort, Christopher L. Ringwalt, Wayne D. Rosamond, Paul R. Chelminski & Stephen W. Marshall. (2019) Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009–2014. Injury Epidemiology 6:1.
Crossref
Jessica Reichert & Lily Gleicher. (2019) Probation clients’ barriers to access and use of opioid use disorder medications. Health & Justice 7:1.
Crossref
Thomas R. Blue, Michael S. Gordon, Robert P. Schwartz, Kathryn Couvillion, Frank J. Vocci, Terrence T. Fitzgerald & Kevin E. O’Grady. (2019) Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine. Addiction Science & Clinical Practice 14:1.
Crossref
Heino Stöver, Daniela Jamin, Ingo Ilja Michels, Bärbel Knorr, Karlheinz Keppler & Daniel Deimel. (2019) Opioid substitution therapy for people living in German prisons—inequality compared with civic sector. Harm Reduction Journal 16:1.
Crossref
Lisa B. Puglisi, Precious S. Bedell, Anna Steiner & Emily A. Wang. (2019) Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference. Current Addiction Reports 6:4, pages 365-373.
Crossref
Alexander C. Tsai, Mathew V. Kiang, Michael L. Barnett, Leo Beletsky, Katherine M. Keyes, Emma E. McGinty, Laramie R. Smith, Steffanie A. Strathdee, Sarah E. Wakeman & Atheendar S. Venkataramani. (2019) Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Medicine 16:11, pages e1002969.
Crossref
John R. Gallagher, Elizabeth A. Wahler, Raychel M. Minasian & Abigail Edwards. (2019) Treating Opioid Use Disorders in Drug Court: Participants’ Views on Using Medication-Assisted Treatments (MATs) to Support Recovery. International Criminal Justice Review 29:3, pages 249-261.
Crossref
Leah Hamilton & Steven Belenko. (2019) Substance Use Disorder Treatment in the Reentry Environment: Service Receipt and Prisoner Community Reintegration. Criminal Justice and Behavior 46:9, pages 1295-1318.
Crossref
Barbara Andraka-Christou, Meghan Gabriel, Jody Madeira & Ross D. Silverman. (2019) Court personnel attitudes towards medication-assisted treatment: A state-wide survey. Journal of Substance Abuse Treatment 104, pages 72-82.
Crossref
Noa Krawczyk, Megan Buresh, Michael S. Gordon, Thomas R. Blue, Michael I. Fingerhood & Deborah Agus. (2019) Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap. Journal of Substance Abuse Treatment 103, pages 1-8.
Crossref
Michael S. Gordon, Frank J. Vocci, Faye Taxman, Marc Fishman, Bikash Sharma, Thomas R. Blue & Kevin E. O'Grady. (2019) A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment. Contemporary Clinical Trials 79, pages 21-27.
Crossref
K. Paul Rezai-Zadeh, Richard N. Engstrom, Andy Sharma, Yiming Chen, Jun Chu, Robin Parker Cox & Mei-Ling Ting Lee. (2019) Generational trends and patterns in readmission within a statewide cohort of clients receiving heroin use disorder treatment in Maryland, 2007–2013. Journal of Substance Abuse Treatment 96, pages 82-91.
Crossref
Andrew Tuck & Lauren Stossel. 2019. The Opioid Epidemic and the Therapeutic Community Model. The Opioid Epidemic and the Therapeutic Community Model 113 132 .
Amanda M. Bunting, Carrie B. Oser, Michele Staton, Katherine S. Eddens & Hannah Knudsen. (2018) Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach. Addiction Science & Clinical Practice 13:1.
Crossref
Andrea K. Finlay, Ingrid Binswanger, Christine Timko, Joel Rosenthal, Sean Clark, Jessica Blue-Howells, Jim McGuire, Hildi Hagedorn, Jessie Wong, James Van Campen & Alex H. S. Harris. (2016) Receipt of Pharmacotherapy for Alcohol Use Disorder by Male Justice-Involved U.S. Veterans Health Administration Patients. Criminal Justice Policy Review 29:9, pages 875-890.
Crossref
Andrea K. Finlay, Ingrid A. Binswanger, Christine Timko, David Smelson, Matthew A. Stimmel, Mengfei Yu, Tom Bowe & Alex H.S. Harris. (2018) Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. Journal of Substance Abuse Treatment 95, pages 43-47.
Crossref
Joseph B. Williams. (2018) Do Pregnant Inmates have a Constitutional Right to Opioid Replacement Therapy?. American Journal of Obstetrics and Gynecology 219:5, pages 455.e1-455.e4.
Crossref
Lauren Brinkley-Rubinstein, Nickolas Zaller, Sarah Martino, David H. Cloud, Erin McCauley, Andrew Heise & David Seal. (2018) Criminal justice continuum for opioid users at risk of overdose. Addictive Behaviors 86, pages 104-110.
Crossref
David Farabee. (2017) Current and Promising Pharmacotherapies for Substance Use Disorders among Justice-Involved Populations. European Journal on Criminal Policy and Research 24:2, pages 145-153.
Crossref
Donna T. Chen, Tomohiro M. Ko, Ashleigh A. Allen, Richard J. Bonnie, Colleen E. Suratt, Paul S. Appelbaum, Edward V. Nunes, Peter D. Friedmann, Joshua D. Lee, Michael S. Gordon, Ryan McDonald, Donna Wilson, Tamara Y. Boney, Sean M. Murphy & Charles P. O’Brien. (2018) Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision. Journal of Empirical Research on Human Research Ethics 13:2, pages 160-172.
Crossref
Kelly E. Moore, Lindsay Oberleitner, Kathryn M.Z. Smith, Kathleen Maurer & Sherry A. McKee. (2018) Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal. Journal of Addiction Medicine 12:2, pages 156-162.
Crossref
Allison G. Robertson, Michele M. Easter, Hsiu-Ju Lin, Linda K. Frisman, Jeffrey W. Swanson & Marvin S. Swartz. (2018) Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness. Journal of Substance Abuse Treatment 86, pages 17-25.
Crossref
Steven Belenko, Ingrid D. Johnson, Faye S. Taxman & Traci Rieckmann. (2016) Probation Staff Attitudes Toward Substance Abuse Treatment and Evidence-Based Practices. International Journal of Offender Therapy and Comparative Criminology 62:2, pages 313-333.
Crossref
William E. SoaresIIIIII, Donna Wilson, Niels Rathlev, Joshua D. Lee, Michael Gordon, Edward V. Nunes, Charles P. O'Brien & Peter D. Friedmann. (2018) Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual. Journal of Substance Abuse Treatment 85, pages 66-69.
Crossref
Peter D. Friedmann, Donna Wilson, Randall HoskinsonJrJr, Michael Poshkus & Jennifer G. Clarke. (2018) Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison. Journal of Substance Abuse Treatment 85, pages 45-48.
Crossref
Allison G. Robertson & Marvin S. Swartz. (2018) Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment. Journal of Substance Abuse Treatment 85, pages 101-104.
Crossref
Peter D. Friedmann, Donna Wilson, Edward V. Nunes, Randall HoskinsonJrJr, Joshua D. Lee, Michael Gordon, Sean M. Murphy, Richard J. Bonnie, Donna T. Chen, Tamara Y. Boney & Charles P. O'Brien. (2018) Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?. Journal of Substance Abuse Treatment 85, pages 61-65.
Crossref
Curtis Bone, Lindsay Eysenbach, Kristen Bell & Declan T. Barry. (2021) Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective. Journal of Law, Medicine & Ethics 46:2, pages 268-271.
Crossref
Michael Linden, Sam Marullo, Curtis Bone, Declan T. Barry & Kristen Bell. (2021) Prisoners as Patients: The Opioid Epidemic, Medication-Assisted Treatment, and the Eighth Amendment. Journal of Law, Medicine & Ethics 46:2, pages 252-267.
Crossref
Noa KrawczykCaroline E. PicherKenneth A. FederBrendan Saloner. (2017) Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine. Health Affairs 36:12, pages 2046-2053.
Crossref
Ashleigh A. Allen, Donna T. Chen, Richard J. Bonnie, Tomohiro M. Ko, Colleen E. Suratt, Joshua D. Lee, Peter D. Friedmann, Michael Gordon, Ryan McDonald, Sean M. Murphy, Tamara Y. Boney, Edward V. Nunes & Charles P. O'Brien. (2017) Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision. Journal of Substance Abuse Treatment 81, pages 66-72.
Crossref
Nina T. Harawa, Bita Amani, Jane Rohde Bowers, Jennifer N. Sayles & William Cunningham. (2017) Understanding interactions of formerly incarcerated HIV-positive men and transgender women with substance use treatment, medical, and criminal justice systems. International Journal of Drug Policy 48, pages 63-71.
Crossref
Dan Abreu, Travis W. Parker, Chanson D. Noether, Henry J. Steadman & Brian Case. (2017) Revising the paradigm for jail diversion for people with mental and substance use disorders: Intercept 0. Behavioral Sciences & the Law 35:5-6, pages 380-395.
Crossref
Emanuel KrebsJeong E. MinElizabeth EvansLibo LiLei LiuDavid HuangDarren UradaThomas KerrYih-Ing HserBohdan Nosyk. (2016) Estimating State Transitions for Opioid Use Disorders. Medical Decision Making 37:5, pages 483-497.
Crossref
Anjalee Sharma, Sharon M. Kelly, Shannon Gwin Mitchell, Jan Gryczynski, Kevin E. O’Grady & Robert P. Schwartz. (2017) Update on Barriers to Pharmacotherapy for Opioid Use Disorders. Current Psychiatry Reports 19:6.
Crossref
Michael S. Gordon, Timothy W. Kinlock, Robert P. Schwartz, Kevin E. O’Grady, Terrence T. Fitzgerald & Frank J. Vocci. (2017) A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release. Drug and Alcohol Dependence 172, pages 34-42.
Crossref
Michael S. Gordon, Frank J. Vocci, Terrence T. Fitzgerald, Kevin E. O'Grady & Charles P. O'Brien. (2017) Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment. Contemporary Clinical Trials 53, pages 130-136.
Crossref
Jonathan P. Caulkins & Peter Reuter. (2017) Dealing More Effectively and Humanely with Illegal Drugs. Crime and Justice 46:1, pages 95-158.
Crossref
Cara Angelotta, Carol J. Weiss, John W. Angelotta & Richard A. Friedman. (2016) A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women. Women's Health Issues 26:6, pages 595-601.
Crossref
Adeeba Kamarulzaman, Stewart E Reid, Amee Schwitters, Lucas Wiessing, Nabila El-Bassel, Kate Dolan, Babak Moazen, Andrea L Wirtz, Annette Verster & Frederick L Altice. (2016) Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. The Lancet 388:10049, pages 1115-1126.
Crossref
David Farabee, Maureen Hillhouse, Timothy Condon, Barbara McCrady, Kathryn McCollister & Walter Ling. (2016) Injectable pharmacotherapy for opioid use disorders (IPOD). Contemporary Clinical Trials 49, pages 70-77.
Crossref
Wayne N. Welsh, Michael Prendergast, Kevin Knight, Hannah Knudsen, Laura Monico, Julie Gray, Sami Abdel-Salam, Shawna Malvini Redden, Nathan Link, Leah Hamilton, Michael S. Shafer & Peter D. Friedmann. (2015) Correlates of Interorganizational Service Coordination in Community Corrections. Criminal Justice and Behavior 43:4, pages 483-505.
Crossref
Ingrid A. Binswanger, Marc F. Stern, Traci E. Yamashita, Shane R. Mueller, Travis P. Baggett & Patrick J. Blatchford. (2016) Clinical risk factors for death after release from prison in Washington State: a nested case-control study. Addiction 111:3, pages 499-510.
Crossref
Andrea K. Finlay, Alex H.S. Harris, Joel Rosenthal, Jessica Blue-Howells, Sean Clark, Jim McGuire, Christine Timko, Susan M. Frayne, David Smelson, Elizabeth Oliva & Ingrid Binswanger. (2016) Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence 160, pages 222-226.
Crossref
J. Mitchell Miller, O. Hayden GriffinIIIIII & Courtney Marciá Gardner. (2016) Opiate treatment in the criminal justice system: a review of crimesolutions.gov evidence rated programs. American Journal of Criminal Justice 41:1, pages 70-82.
Crossref
Wayne N. Welsh, Hannah K. Knudsen, Kevin Knight, Lori Ducharme, Jennifer Pankow, Terry Urbine, Adrienne Lindsey, Sami Abdel-Salam, Jennifer Wood, Laura Monico, Nathan Link, Carmen Albizu-Garcia & Peter D. Friedmann. (2015) Effects of an Organizational Linkage Intervention on Inter-Organizational Service Coordination Between Probation/Parole Agencies and Community Treatment Providers. Administration and Policy in Mental Health and Mental Health Services Research 43:1, pages 105-121.
Crossref
Michael S. Gordon, Timothy W. Kinlock, Frank J. Vocci, Terrence T. Fitzgerald, Asli Memisoglu & Bernard Silverman. (2015) A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners. Journal of Substance Abuse Treatment 59, pages 52-58.
Crossref
Peter D. Friedmann, Donna Wilson, Hannah K. Knudsen, Lori J. Ducharme, Wayne N. Welsh, Linda Frisman, Kevin Knight, Hsiu-Ju Lin, Amy James, Carmen E. Albizu-Garcia, Jennifer Pankow, Elizabeth A. Hall, Terry F. Urbine, Sami Abdel-Salam, Jamieson L. Duvall & Frank J. Vocci. (2015) Effect of an Organizational Linkage Intervention on Staff Perceptions of Medication-Assisted Treatment and Referral Intentions in Community Corrections. Journal of Substance Abuse Treatment 50, pages 50-58.
Crossref
Maxim Polonsky, Lyuba Azbel, Jeffrey A. Wickersham, Faye S. Taxman, Evgeny Grishaev, Sergey Dvoryak & Frederick L. Altice. (2015) Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS. Drug and Alcohol Dependence 148, pages 47-55.
Crossref
Joshua D. Lee, Peter D. Friedmann, Tamara Y. Boney, Randall A. HoskinsonJr.Jr., Ryan McDonald, Michael Gordon, Marc Fishman, Donna T. Chen, Richard J. Bonnie, Timothy W. Kinlock, Edward V. Nunes, James W. Cornish & Charles P. O'Brien. (2015) Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: Rationale and design of a randomized controlled effectiveness trial. Contemporary Clinical Trials 41, pages 110-117.
Crossref
David Farabee, Richard A. Rawson & Tarek A. Gawad. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives 1129 1144 .
C. Brendan Clark, Peter S. Hendricks, Peter S. Lane, Lindsay Trent & Karen L. Cropsey. (2014) Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision. Addictive Behaviors 39:12, pages 1736-1740.
Crossref
Ariel S. Ludwig & Roger H. Peters. (2014) Medication-assisted treatment for opioid use disorders in correctional settings: An ethics review. International Journal of Drug Policy 25:6, pages 1041-1046.
Crossref
Ingrid A. Binswanger. (2014) Commentary on Forsyth et al . (2014): Subgroup differences in post-release mortality-implications for access to diverse and effective treatments . Addiction 109:10, pages 1684-1685.
Crossref
B. Nosyk, L. Li, E. Evans, D. Huang, J. Min, T. Kerr, M.L. Brecht & Y.I. Hser. (2014) Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users. Drug and Alcohol Dependence 140, pages 69-77.
Crossref
Shannon Gwin Mitchell, Jan Gryczynski, Sharon M. Kelly, Kevin E. O’Grady, Jerome H. Jaffe, Yngvild K. Olsen & Robert P. Schwartz. (2013) Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status. Journal of Drug Issues 44:1, pages 69-82.
Crossref
Peter D Friedmann, Lori J Ducharme, Wayne Welsh, Linda Frisman, Kevin Knight, Timothy Kinlock, Shannon Gwin Mitchell, Elizabeth Hall, Terry Urbine, Michael Gordon, Sami Abdel-Salam, Dan O’Connell, Carmen Albizu-Garcia, Hannah Knudsen, Jamieson Duval, Juliane Fenster & Jennifer Pankow. (2013) A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol. Health & Justice 1:1.
Crossref
Steven Belenko, Matthew Hiller & Leah Hamilton. (2013) Treating Substance Use Disorders in the Criminal Justice System. Current Psychiatry Reports 15:11.
Crossref
Archana Krishnan, Jeffrey A. Wickersham, Ehsan Chitsaz, Sandra A. Springer, Alison O. Jordan, Nick Zaller & Frederick L. Altice. (2012) Post-Release Substance Abuse Outcomes Among HIV-Infected Jail Detainees: Results from a Multisite Study. AIDS and Behavior 17:S2, pages 171-180.
Crossref
Harlan Matusow, Samuel L. Dickman, Josiah D. Rich, Chunki Fong, Dora M. Dumont, Carolyn Hardin, Douglas Marlowe & Andrew Rosenblum. (2013) Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment 44:5, pages 473-480.
Crossref
Joanne Csete & Holly Catania. (2013) Methadone treatment providers’ views of drug court policy and practice: a case study of New York State. Harm Reduction Journal 10:1, pages 35.
Crossref
William B. Lawson & Anthony Lawson. 2013. Crime, HIV and Health: Intersections of Criminal Justice and Public Health Concerns. Crime, HIV and Health: Intersections of Criminal Justice and Public Health Concerns 81 91 .
Hannah K. Knudsen & Paul M. Roman. (2012) Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders. Journal of Addiction Medicine 6:4, pages 280-286.
Crossref
. (2012) Current World Literature. Current Opinion in Psychiatry 25:6, pages 565-573.
Crossref
Sandra A. Springer, Jingjun Qiu, Ali Shabahang Saber-Tehrani & Frederick L. Altice. (2012) Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners. PLoS ONE 7:5, pages e38335.
Crossref
Ekaterina Pivovarova, Faye S. Taxman, Alexandra K. Boland, David Smelson, Stephenie C. Lemon & Peter D. Friedmann. (2022) Facilitators and Barriers to Collaboration between Drug Courts and Community-Based Medication for Opioid Use Disorder Providers. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.